The drastic reduction in indirect costs is not a path to innovation or cost savings — it’s a threat to U.S.’s position as ...

Q4 2024 Management View CEO Nicholas Woodman highlighted that Q4 results were in line or slightly better than guidance and emphasized proactive supply chain strategies to mitigate the impact of US ...

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...